Literature DB >> 1947042

Computed tomography. Focal and diffuse liver disease.

W D Foley1, R J Jochem.   

Abstract

Contrast enhanced CT is very accurate in the detection of focal hepatic disease. Lesion characterization is a more complex issue, in some instances requiring a combination of CT and other diagnostic tests or biopsy for accurate diagnosis. Although CT remains the modality of choice in the evaluation of suspected focal hepatic disease, this role may change if progress in MR imaging leads to further improvements in lesion detection and characterization.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1947042

Source DB:  PubMed          Journal:  Radiol Clin North Am        ISSN: 0033-8389            Impact factor:   2.303


  5 in total

1.  Characterization of hypoechoic focal hepatic lesions in patients with fatty liver: diagnostic performance and confidence of contrast-enhanced ultrasound.

Authors:  Tommaso Vincenzo Bartolotta; Adele Taibbi; Massimo Galia; Giuseppe Runza; Domenica Matranga; Massimo Midiri; Roberto Lagalla
Journal:  Eur Radiol       Date:  2006-10-03       Impact factor: 5.315

2.  Liver haemangiomas undetermined at grey-scale ultrasound: contrast-enhancement patterns with SonoVue and pulse-inversion US.

Authors:  Tommaso Vincenzo Bartolotta; Massimo Midiri; Emilio Quaia; Michele Bertolotto; Massimo Galia; Filippo Cademartiri; Roberto Lagalla
Journal:  Eur Radiol       Date:  2004-12-21       Impact factor: 5.315

Review 3.  Successful aspiration and ethanol sclerosis of a large, symptomatic, simple liver cyst: case presentation and review of the literature.

Authors:  Wojciech C Blonski; Mical S Campbell; Thomas Faust; David C Metz
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

4.  Focal nodular hyperplasia in normal and fatty liver: a qualitative and quantitative evaluation with contrast-enhanced ultrasound.

Authors:  Tommaso Vincenzo Bartolotta; Massimo Midiri; Michele Scialpi; Elio Sciarrino; Massimo Galia; Roberto Lagalla
Journal:  Eur Radiol       Date:  2003-10-10       Impact factor: 5.315

Review 5.  Malignant schwannoma of the liver.

Authors:  Y Morikawa; Y Ishihara; N Matsuura; H Miyamoto; K Kakudo
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.